Case Study 1 — The Screening That Became Diagnostic

A real, documented policy structure with a statutory fix. Tier 1 for the framework and the statute; qualitative for magnitudes.

Background

Section 12.9 gave the rule in one sentence: a test is a screening when the patient has no signs or symptoms of the condition being tested for, and the moment a sign, symptom, or diagnosis exists, it is diagnostic.

That sentence decides whether a preventive test is free.

The Affordable Care Act requires most health plans to cover a defined set of preventive services without cost sharing — no deductible, no copayment, no coinsurance — when delivered in network. The list includes recommended cancer screenings. Medicare separately covers specified screening services, some with the beneficiary's cost sharing waived.

The benefit attaches to the screening. Which means it attaches to a coding determination, made after the fact, from documentation.

The problem, in its clearest form

A patient with no symptoms, at average risk, presents for a screening colonoscopy. They have been told — accurately — that screening colonoscopy is a covered preventive service with no cost sharing.

During the procedure, a polyp is found and removed.

The screening has just become a therapeutic procedure. The patient walks out having had exactly the service they were promised, plus something extra that was found and dealt with, and the claim now describes a polypectomy rather than a screening.

Under the ordinary rules, that is a diagnostic and therapeutic service, subject to the deductible and coinsurance.

And the patient receives a bill for a test they were told was free — because it worked.

The perverse incentive is obvious and was widely recognized: a screening program whose financial penalty falls precisely on the patients in whom the screening found something.

The fixes, and they are partial

Modifiers. The coding system's answer is a modifier that preserves the screening character of the service. Medicare uses one modifier for a screening colonoscopy that becomes diagnostic; commercial plans under the preventive-services rule generally look for a different modifier indicating that the service was preventive. Chapter 14 covers both, and Chapter 34 §34.11 works the claim.

Guidance. Federal agencies issued FAQs addressing polyp removal during a screening colonoscopy under the preventive services requirement, clarifying that plans may not impose cost sharing for a polypectomy performed during a screening colonoscopy — because the polypectomy is integral to the screening.

And a statute, for Medicare specifically. The Consolidated Appropriations Act, 2021, § 122 addressed the Medicare version of the problem, which had a different shape: because of how the Medicare benefit was structured, a screening colonoscopy that became diagnostic triggered beneficiary coinsurance. The provision phases that coinsurance down to zero over a period of years, in defined steps by calendar year.

Verify the current percentage. It steps down on a published schedule, and any figure printed in a book is a snapshot. This is precisely the "changing numbers" problem the style of this book keeps flagging.

What it shows

First, a coding determination decides a benefit. Chapter 12 §12.9 presented screening-versus- diagnostic as a coding rule. It is also, in direct and immediate terms, the rule that determines whether a patient pays. The coder is not adjacent to that decision. The coder makes it, from the documentation.

Second, the documentation governs and the patient's intent does not. A patient who came in for a screening, believed they were getting a screening, and was told it was a screening still has a diagnostic service if the record documents symptoms. §12.9 said the determination is made from the record, "not what the order form's checkbox said" — and this is where that matters.

Third, it is a case where the coding system produced a bad outcome and the response was legislative. That is worth noticing. The modifier existed, the coding was correct, the claims were accurate, and the result was patients being billed for successful screenings. No amount of coding accuracy fixes a rule that produces the wrong incentive, and the fix had to come from outside the coding system.

Fourth, the fixes are partial and differ by payer, which is the ordinary state of American healthcare and the reason Chapter 3 §3.1's advice — use Medicare as the default hypothesis, never as the answer — keeps recurring. The Medicare fix and the commercial fix are different mechanisms with different modifiers on different timetables.

Outcome

Both mechanisms operate. Screening colonoscopies that become diagnostic are handled differently depending on the payer, the modifier requirements differ, and the Medicare coinsurance phase-down continues on its statutory schedule.

Patients still receive unexpected bills, for reasons that are frequently adjacent to but not identical to this one — a polyp removal handled correctly, but a screening performed at a non-preventive interval, or ordered with a diagnostic indication because the ordering provider documented a symptom, or performed by an out-of-network anesthesiologist.

The general lesson survives the specific fix: the boundary between preventive and diagnostic is a documentation boundary, it moves during procedures, and the person who explains the resulting bill is usually in a business office.

The modifiers, the FAQ guidance, and the statutory phase-down schedule are all subject to change. Verify current requirements with the payer and with CMS.

The lesson

The screening-versus-diagnostic determination is a coding decision with a direct consumer-finance consequence, and it is made from the record.

Three carry-forwards:

Read the order and the indication before the procedure is coded. A screening ordered for an asymptomatic patient and a colonoscopy ordered for rectal bleeding are different services from the first moment, and the difference is in the documentation before anyone enters the room.

Know your payers' modifier requirements, because they differ and the difference determines whether the patient is billed.

And when a patient calls about a bill for a screening, start by finding out what the record said. Chapter 32 §32.10 covers the conversation. The technical answer is usually available in ninety seconds, and the patient's experience of the call depends entirely on whether the person answering knows where to look.

Discussion questions

1. The coding was accurate and the outcome was bad. What does that suggest about the relationship between coding rules and policy outcomes generally?

2. The patient's belief that they were getting a free screening is irrelevant to the coding. Is that defensible? Construct the argument that intent should matter and say what it would cost.

3. Medicare and commercial plans fixed this differently, with different modifiers and different mechanisms. What does a coder in a practice that sees both do, practically?

4. The Medicare fix phases coinsurance to zero over years rather than immediately. Why might a statute be written that way, and who bears the cost during the phase-down?

5. Name another situation in this book where a determination made from documentation has a direct consumer-finance consequence. What do the two have in common?